Search for content, post, videos

Gedea Biotech raises 1.3 million EUR

The money has been raised for additional development activities of their product pHyph for antibiotic free treatment of vaginal infections. The funds will be used for an ongoing proof-of-concept study for the treatment of Vulvo Vaginal Candidiasis (VVC) with pHyph, partially financed by a recent
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.